Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Cash: 2016-2025

Historic Change in Cash for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Sep 2025 value amounting to -$83.4 million.

  • Rhythm Pharmaceuticals' Change in Cash rose 26.97% to -$83.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 128.14%. This contributed to the annual value of $29.2 million for FY2024, which is 143.19% up from last year.
  • Rhythm Pharmaceuticals' Change in Cash amounted to -$83.4 million in Q3 2025, which was down 382.07% from $29.6 million recorded in Q2 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Change in Cash peaked at $108.2 million during Q2 2024, and registered a low of -$114.1 million during Q3 2024.
  • In the last 3 years, Rhythm Pharmaceuticals' Change in Cash had a median value of -$4.5 million in 2023 and averaged -$6.8 million.
  • In the last 5 years, Rhythm Pharmaceuticals' Change in Cash slumped by 193.40% in 2023 and then spiked by 1,697.11% in 2024.
  • Over the past 5 years, Rhythm Pharmaceuticals' Change in Cash (Quarterly) stood at -$33.1 million in 2021, then tumbled by 73.32% to -$57.4 million in 2022, then spiked by 92.14% to -$4.5 million in 2023, then soared by 1,022.38% to $41.6 million in 2024, then rose by 26.97% to -$83.4 million in 2025.
  • Its Change in Cash was -$83.4 million in Q3 2025, compared to $29.6 million in Q2 2025 and $17.0 million in Q1 2025.